Bombay High Court sent notice to the Centre, SII, and Bill Gates, after a petitioner claimed that her daughter died from the Covishield vaccine
The petitioner has asked for compensation in the amount of Rs. 1,000 Crore from the vaccine producer.
SII
Stay updated with the latest news and articles about SII.
Latest Articles
Serum Institute of India: 1 crore doses of Quadrivalent Human Papillomavirus vaccine by December 2022
Serum Institute tells Centre it can supply 1 crore doses of its indigenously developed Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer, by December 2022
DGCI permits Serum Institute of India to manufacture vaccines against Omicron
SII has received permission and licences to produce SARS-CoV-2rS drug substances for research, test and analysis.
WHO approves SII’s Covovax for emergency use
Serum Institute of India gets license to produce over two billion doses of the vaccine Covovax.
India may resume the export of COVID-19 vaccines by the end of the year: SII CEO Adar Poonawalla
Serum Institute of India (SII) CEO Adar Poonawalla stated that India may resume the export of COVID-19 vaccines by the end of the year.
Pune: Production of Covovax started at SII, shows 90.4 per cent efficacy
The statement added that the study enrolled at least 29,960 candidates across 119 sites in the US and Mexico to evaluate efficacy, safety and immunogenicity of the vaccine. Novavax said that the Covovax vaccine had showed 93 per cent efficacy against predominantly circulating variants of concern and the variants of interest.
Serum Institute CEO Adar Poonawalla to get Y category security cover
"Y" Category security involves the presence of 11 security personnel-There are one or two commandos and the rest are policemen.
Showing 15 of 18 articles